Practice Variation for Platelet Transfusion in Patients with Severe Refractory Thrombocytopenia: A Survey of Critical

Alina O Dulu1, Sanjay Chawla1,2, Neema Jayachamarajapura Onkaramurthy1

  • 1Critical Care Center, Department of Anesthesiology & Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

BackgroundSevere thrombocytopenia refractory to platelet transfusion is an increasingly common issue and poses challenges for safely performing procedures in the intensive care unit (ICU).ObjectiveTo describe platelet transfusion thresholds and strategies ICU clinicians use when performing invasive procedures with general low bleeding risk in patients with severe refractory thrombocytopenia (below 5000/mm3), a scenario for which no current guideline recommendations exist.DesignCross-sectional web-based survey of ICU clinicians in adult oncologic ICUResultsOf 110 ICU clinicians 65 (59%) completed the survey (median IQR age: 36 years (31-43), 63% female). For placing a central venous catheter (CVC) majority (60%) chose a platelet transfusion threshold <20 000/mm3, while 40% chose a threshold ≥20 000/mm3. Lower thresholds were used frequently by Fellows, APPs, and clinicians with ≤5 years experience in ICU or < 50 CVC placements experience, whereas CCM attendings and more experienced clinicians favored higher thresholds (P = .015). Majority (74%) transfused one unit of platelets while performing the procedure under ultrasound guidance. The internal jugular vein was the preferred site (63%). Similar strategies and platelet thresholds were employed for hemodyalisis catheter (HD) placement. Desmopressin was administered by 55% before HD catheter placement. Thirty-seven percent reported patients with platelet counts below 20 000/mm3 undergoing line placement never required post-procedure transfusion for bleeding.ConclusionsThe survey shows that ICU clinicians are safely and comfortably performing procedures at platelet thresholds below 20,000, revealing a gap between guideline recommendations and real-world practice and a need for additional evidence to guide invasive procedures in this population.

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.4K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.9K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.6K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.9K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
481
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.0K